Use the combined antitumor agent with kinase inhibitory activity

• 收藏
• 分享

专利权人:

EISAI R& D MANAGEMENT CO. LTD.

发明人:

申请号：

IL22369512

公开号：

IL223695A

申请日:

2012.12.17

申请国别(地区):

IL

年份:

2017

代理人:

摘要：

It discloses using the compound of general formula (I) expression of antitumor agent or its pharmacologically acceptable salt and formula (II) or its pharmacologically acceptable salt. In the case that the antitumor agent shows significant antitumaous effect and access, each above compound is used alone. In addition, the antitumor agent shows the various cancers of antitumaous effect. (in formula, R

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/